Topical Amphotericin B 3% Cream

amphotericin B · Drugs for Neglected Diseases initiative (DNDi)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical Amphotericin B 3% Cream, covering 2016-07-26 to 2016-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia [Phase 1, Phase 2]